Area of research
Hematology · Genetics
Research interest
Research interests include Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Eosinophilic Disorders and Syndromes, and Acute Lymphoblastic Leukemia research.
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
Update of Olverembatinib (HQP1351) Overcoming Ponatinib and/or Asciminib Resistance in Patients (Pts) with Heavily Pretreated/Refractory Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph + ALL)
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Interim analysis (IA) of OPTIC: A dose-ranging study of three ponatinib (PON) starting doses.
The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
Long‐term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up